|
|
 |
|
| | |
| | | | | |
modification
|
|
PR:000000577 |
smad3 isoform 1 acetylated and phosphorylated form
|
SMAD3/iso:1/AcPhos+
|
"A smad3 isoform 1 that includes at least one acetylated residue and at least one phosphorylated residue." [PRO:CNA]
|
|
|
|
|
|
|
| | | | |
| | | |
modification
|
|
PR:000000657 |
smad3 isoform 1 acetylated and phosphorylated 1
|
SMAD3/iso:1/AcPhos:1
|
"A smad3 isoform 1 acetylated and phosphorylated form in which the phosphorylation occurs upon TGF-beta receptor activation and which has been further acetylated at a Lys residue within the MH1 domain by coactivators, such as CBP and EP300. Example: UniProtKB:P84022-1, Lys-19, MOD:00064|Ser-423/Ser-425, MOD:00046." [PMID:17074756]
|
|
|
|
|
|
|
| | | | | | |
| |
organism-modification
|
|
PR:000036557 |
smad3 isoform 1 acetylated and phosphorylated 1 (human)
|
hSMAD3/iso:1/AcPhos:1
|
"A smad3 isoform 1 acetylated and phosphorylated 1 in human. UniProtKB:P84022-1, Lys-19, MOD:00064|Ser-423/Ser-425, MOD:00046." [PMID:17074756, PRO:CNA]
|
Yes |
|
|
|
|
